A medication initially designed to regulate blood sugar eventually transformed the management of obesity. Now it may hold clues to understanding the biological roots of ... Mar 10
Medical innovation has provided powerful tools to address one of the world’s most pressing health challenges. But the path to lasting wellness still requires ... Mar 07
The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ... Dec 12
Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare Ltd., today announced the launch of the Complete Care ... Dec 04
Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined.... Aug 11
India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads.... Aug 01
Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
-Advertisements-
.jpeg)
Wednesday, August 05, 2026
.jpeg)
.jpeg)
.jpeg)
_logo_(1).png){kind=logo}
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpg)
.jpg)